预产期胆膜炎对肺超声波评分的影响,用于指导表面活性剂替代

Laura Vivalda1, Barbara Loi1,2, Valeria Bisceglie1

  • 1Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Medical Center, Paris-Saclay University Hospitals, APHP, Paris, France.

Pediatric pulmonology
|June 28, 2023
PubMed
概括

临床胆膜炎 (CC) 不会影响早产儿的肺超声波得分 (LUS),除非严重的炎症引发新生儿急性呼吸应急综合征 (NARDS). NARDS的发生是影响LUS和表面活性剂治疗决策的关键因素.